Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude.

Adult Aged Anti-Obesity Agents / therapeutic use Attitude of Health Personnel Body Mass Index Drug Prescriptions Drug Utilization Female General Practitioners / psychology Guideline Adherence Health Knowledge, Attitudes, Practice Health Services Misuse Humans Male Middle Aged Obesity / diagnosis Practice Guidelines as Topic Retrospective Studies
General practice Obesity Pharmacotherapy Prescription

Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 10 04 2020
revised: 19 05 2020
accepted: 23 05 2020
pubmed: 6 6 2020
medline: 2 3 2021
entrez: 6 6 2020
Statut: ppublish

Résumé

Obesity is a worldwide growing problem for the health care systems and its treatment is strongly recommended. Orlistat, naltrexone/bupropion, and liraglutide are approved for weight loss in Italy in patients with a Body Mass Index (BMI) ≥ 30 kg/m

Identifiants

DOI: 10.1016/j.biopha.2020.110320 PMID: 32502842
pubmed: 32502842
pii: S0753-3322(20)30512-6
doi: 10.1016/j.biopha.2020.110320
pii:
doi:

Substances chimiques

Anti-Obesity Agents 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

110320

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that there are no conflicts of interest.

Auteurs

Francesco Squadrito (F)

Department of Clinical and Experimental Medicine, University of Messina, c/o AOU Policlinico G. Martino, Via C. Valeria Gazzi, 98125, Messina, Italy. Electronic address: fsquadrito@unime.it.

Michelangelo Rottura (M)

Department of Clinical and Experimental Medicine, University of Messina, c/o AOU Policlinico G. Martino, Via C. Valeria Gazzi, 98125, Messina, Italy.

Natasha Irrera (N)

Department of Clinical and Experimental Medicine, University of Messina, c/o AOU Policlinico G. Martino, Via C. Valeria Gazzi, 98125, Messina, Italy.

Letteria Minutoli (L)

Department of Clinical and Experimental Medicine, University of Messina, c/o AOU Policlinico G. Martino, Via C. Valeria Gazzi, 98125, Messina, Italy.

Alessandra Bitto (A)

Department of Clinical and Experimental Medicine, University of Messina, c/o AOU Policlinico G. Martino, Via C. Valeria Gazzi, 98125, Messina, Italy.

Maria Antonietta Barbieri (MA)

Department of Clinical and Experimental Medicine, University of Messina, c/o AOU Policlinico G. Martino, Via C. Valeria Gazzi, 98125, Messina, Italy.

Giuseppe Cicala (G)

Department of Clinical and Experimental Medicine, University of Messina, c/o AOU Policlinico G. Martino, Via C. Valeria Gazzi, 98125, Messina, Italy.

Anna Mecchio (A)

Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, c/o AOU Policlinico G. Martino, Via C. Valeria Gazzi, 98125, Messina, Italy.

Giovanni Pallio (G)

Department of Clinical and Experimental Medicine, University of Messina, c/o AOU Policlinico G. Martino, Via C. Valeria Gazzi, 98125, Messina, Italy.

Sebastiano Marino (S)

Department of Clinical and Experimental Medicine, University of Messina, c/o AOU Policlinico G. Martino, Via C. Valeria Gazzi, 98125, Messina, Italy.

Giacomo Picciolo (G)

Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, c/o AOU Policlinico G. Martino, Via C. Valeria Gazzi, 98125, Messina, Italy.

Domenica Altavilla (D)

Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, University of Messina, c/o AOU Policlinico G. Martino, Via C. Valeria Gazzi, 98125, Messina, Italy.

Vincenzo Arcoraci (V)

Department of Clinical and Experimental Medicine, University of Messina, c/o AOU Policlinico G. Martino, Via C. Valeria Gazzi, 98125, Messina, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents antiobésité › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Attitude du personnel soignant › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Biométrie › Anthropométrie › Indice de masse corporelle › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Services pharmaceutiques › Ordonnances › Ordonnances médicamenteuses › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › Administration des services de santé › Organisation et administration › Administration pharmacie › Utilisation médicament › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Personnel de santé › Médecins › Médecins généralistes › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Adhésion aux directives › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Attitude envers la santé › Connaissances, attitudes et pratiques en santé › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Attitude envers la santé › Mésusage des services de santé › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Obésité › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Recommandations comme sujet › Guides de bonnes pratiques cliniques comme sujet › Anti-obesity drug therapy in clinical...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Anti-obesity drug therapy in clinical...